• StatusActive
  • StrategyFlagship



Apotex is a Canadian-based, leading global health company with a diversified portfolio of over 600 generic pharmaceutical, over-the-counter and biosimilar product families across all major therapeutic areas. Headquartered in Toronto, Ontario, Apotex exports to more than 100 countries and territories and operates in 45 countries. Apotex employs nearly 8,000 people worldwide in manufacturing, R&D and commercial operations, with a significant presence in Canada, the United States, Mexico and India.

SK Capital acquired Apotex in April 2023.